| Richard Sk Young, MD | |
|
282 Washington St, Hartford, CT 06106-3322 | |
| (860) 837-7500 | |
| (860) 837-7550 |
| Full Name | Richard Sk Young |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 51 Years |
| Location | 282 Washington St, Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093797979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0402X | Psychiatry & Neurology - Neurology With Special Qualifications In Child Neurology | 027408 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Connecticut Children's Specialty Group, Inc | 6002720117 | 152 |
News Archive
International Isotopes Inc. announces completion of an agreement with URENCO USA to provide assistance to International Isotopes on its Nuclear Regulatory Commission licensing and State of New Mexico permitting processes.
Identifying diseases at an early, presymptomatic stage may offer the best chance for establishing proper treatment and improving patient outcomes. A new technique known as immunosignaturing harnesses the human immune system as an early warning sentry-one acutely sensitive to changes in the body that may be harbingers of illness.
Two papers in the August 1 issue of Genes & Development explore the genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2.
Techne Corporation's consolidated net earnings for the quarter ended September 30, 2010 decreased 1.5% to $26.4 million or $.71 per diluted share compared with $26.8 million or $.72 per diluted share for the quarter ended September 30, 2009.
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer, regardless of the duration of use, the formulation, estrogen dose, regimen or route of administration, according to a study in the July 15 issue of JAMA.
› Verified 4 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
International Isotopes Inc. announces completion of an agreement with URENCO USA to provide assistance to International Isotopes on its Nuclear Regulatory Commission licensing and State of New Mexico permitting processes.
Identifying diseases at an early, presymptomatic stage may offer the best chance for establishing proper treatment and improving patient outcomes. A new technique known as immunosignaturing harnesses the human immune system as an early warning sentry-one acutely sensitive to changes in the body that may be harbingers of illness.
Two papers in the August 1 issue of Genes & Development explore the genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2.
Techne Corporation's consolidated net earnings for the quarter ended September 30, 2010 decreased 1.5% to $26.4 million or $.71 per diluted share compared with $26.8 million or $.72 per diluted share for the quarter ended September 30, 2009.
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer, regardless of the duration of use, the formulation, estrogen dose, regimen or route of administration, according to a study in the July 15 issue of JAMA.
› Verified 4 days ago
| Entity Name | Connecticut Children's Specialty Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669448882 PECOS PAC ID: 6002720117 Enrollment ID: O20031113000468 |
News Archive
International Isotopes Inc. announces completion of an agreement with URENCO USA to provide assistance to International Isotopes on its Nuclear Regulatory Commission licensing and State of New Mexico permitting processes.
Identifying diseases at an early, presymptomatic stage may offer the best chance for establishing proper treatment and improving patient outcomes. A new technique known as immunosignaturing harnesses the human immune system as an early warning sentry-one acutely sensitive to changes in the body that may be harbingers of illness.
Two papers in the August 1 issue of Genes & Development explore the genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2.
Techne Corporation's consolidated net earnings for the quarter ended September 30, 2010 decreased 1.5% to $26.4 million or $.71 per diluted share compared with $26.8 million or $.72 per diluted share for the quarter ended September 30, 2009.
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer, regardless of the duration of use, the formulation, estrogen dose, regimen or route of administration, according to a study in the July 15 issue of JAMA.
› Verified 4 days ago
| Entity Name | Hospital For Special Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477534089 PECOS PAC ID: 7810985637 Enrollment ID: O20040506000578 |
News Archive
International Isotopes Inc. announces completion of an agreement with URENCO USA to provide assistance to International Isotopes on its Nuclear Regulatory Commission licensing and State of New Mexico permitting processes.
Identifying diseases at an early, presymptomatic stage may offer the best chance for establishing proper treatment and improving patient outcomes. A new technique known as immunosignaturing harnesses the human immune system as an early warning sentry-one acutely sensitive to changes in the body that may be harbingers of illness.
Two papers in the August 1 issue of Genes & Development explore the genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2.
Techne Corporation's consolidated net earnings for the quarter ended September 30, 2010 decreased 1.5% to $26.4 million or $.71 per diluted share compared with $26.8 million or $.72 per diluted share for the quarter ended September 30, 2009.
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer, regardless of the duration of use, the formulation, estrogen dose, regimen or route of administration, according to a study in the July 15 issue of JAMA.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Sk Young, MD 1450 Chapel St, New Haven, CT 06511-4405 Ph: (860) 837-7500 | Richard Sk Young, MD 282 Washington St, Hartford, CT 06106-3322 Ph: (860) 837-7500 |
News Archive
International Isotopes Inc. announces completion of an agreement with URENCO USA to provide assistance to International Isotopes on its Nuclear Regulatory Commission licensing and State of New Mexico permitting processes.
Identifying diseases at an early, presymptomatic stage may offer the best chance for establishing proper treatment and improving patient outcomes. A new technique known as immunosignaturing harnesses the human immune system as an early warning sentry-one acutely sensitive to changes in the body that may be harbingers of illness.
Two papers in the August 1 issue of Genes & Development explore the genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2.
Techne Corporation's consolidated net earnings for the quarter ended September 30, 2010 decreased 1.5% to $26.4 million or $.71 per diluted share compared with $26.8 million or $.72 per diluted share for the quarter ended September 30, 2009.
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer, regardless of the duration of use, the formulation, estrogen dose, regimen or route of administration, according to a study in the July 15 issue of JAMA.
› Verified 4 days ago
Bentley Andrew Strockbine, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 200 Retreat Ave, Hartford, CT 06106 Phone: 860-545-7410 | |
Dr. Alfred Herzog, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 80 Seymour Street, Hartford Hospital, Hartford, CT 06102 Phone: 860-545-3501 | |
J Daane Logsdon, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 200 Retreat Ave, Hartford Hospital Psychiatry Dept, Hartford, CT 06106 Phone: 860-545-7250 | |
Crystal Diane Salcido, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 200 Retreat Avenue, Hartford Hospital Psychiatry Dept, Hartford, CT 06106 Phone: 860-545-7064 | |
Robert F Swords, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 675 Tower Ave, Suite 301, Hartford, CT 06112 Phone: 860-714-2750 Fax: 860-714-8591 | |
Samira Savill Solomon, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 200 Retreat Ave, Hartford Hospital Psychiatry Dept., Hartford, CT 06106 Phone: 860-545-7330 | |
Dr. Ainsley E Backman, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 200 Retreat Ave, Hartford, CT 06106 Phone: 860-545-7062 |